Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor

Clinical trial NCT05745337 · UNKNOWN

Trial details

NCT number: NCT05745337
Sponsor: University of Vermont
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Atrial Fibrillation Diastolic Dysfunction HFpEF - Heart Failure With Preserved Ejection Fraction

Start date: 2023-02-06
Primary completion: 2023-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.